CALGARY, Alberta, Jan. 17, 2025 (GLOBE NEWSWIRE) -- ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), ...

FOR centuries, gout has been a deeply misunderstood disease, associated only with jolly, indulgent, and often big men. When Henry VIII was diagnosed, it became firmly entrenched in popular belief ...

Diagnosis Tophaceous gout associated with urate nephropathy in a patient intolerant to allopurinol. Management Acute polyarthritis was successfully managed by intravenous bolus methylprednisolone ...

XORTX Therapeutics Inc ( ($TSE:XRTX) ) has issued an update. XORTX Therapeutics Inc. announced a change of auditor, appointing Davidson & Company ...

One regimen to consider for those commencing allopurinol at an early stage of gout presentation in a patient with normal renal function is to wait 3 weeks after an acute attack resolves ...

Opinion: "They all enjoy salaries exceeding those enjoyed by other countries' prime ministers," writes Tim Hamlett.

Zurampic is approved by the FDA for hyperuricemia associated with uncontrolled gout, in combination with a xanthine oxidase inhibitor (XOI). Duzallo is a combination of lesinurad and allopurinol ...

current drugs like allopurinol and febuxostat aren’t able to achieve that objective, and there are estimated to be around 160,000 people facing with refractory gout in the US. If approved ...

Gout flares among adults in the United States are significantly underreported to healthcare providers, with nearly 72% of flares either not reported or pretreated/prevented by patients, according to ...

Find Gout Disease stock video, 4K footage, and other HD footage from iStock. Get higher quality Gout Disease content, for less—All of our 4K video clips are the same price as HD. Video Back Videos ...

Experience the detailed anatomy of gout inflammation affecting the big toe joint in this informative video. Explore the intricate structures and physiological processes underlying this painful ...

Objective Verinurad (RDEA3170) is a high-affinity, selective URAT1 inhibitor in development for treating gout and asymptomatic hyperuricaemia. This study evaluated the pharmacodynamics, ...